Clinical Trial Update: IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating the combination of induced pluripotent stem cell–derived cardiomyocytes (IPSC-CMs) with LVAD or CABG for treating h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: HELP Therapeutics Co., Ltd. | Conditions: Heart Failure, Heart Failure At NYHA Stage III or IV | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING